Actor Rajinikanth defends Govt on CAA, says it won't affect Indian Muslims

Mumbai, Jul 3: Bollywood woke up to the shock news of their beloved 'masterji' Saroj Khan's death on Friday, with many celebrities remembering the veteran choreographer as a "genius" and an "inspiration" to others.

Khan, the name behind some of the most famous songs in Bollywood such as "Dhak Dhak" and "Ek Do Teen", died of cardiac arrest early on Friday morning. She was 71.

Superstar Akshay Kumar termed Khan's demise as a "huge loss" to the industry.

"Woke up to the sad news that legendary choreographer #SarojKhan ji is no more. She made dance look easy almost like anybody can dance, a huge loss for the industry. May her soul rest in peace," he tweeted.

Choreographer Farah Khan said she was among the countless artistes who were inspired by Khan's work.

"Rest in peace Sarojji... You were an inspiration to many, myself included. Thank you for the songs," she wrote on Twitter.

Choreographer-turned-filmmaker Remo D'Souza said, "#RIP Saroji, you will be missed... Big loss to dance fraternity."

Actor Taapsee Pannu said she will forever cherish the memories of working with the veteran choreographer.

"At least I had a chance to dance in your company. I am going to hold on to those memories tight... real tight. We lose another star to the sky. Your songs will make every girl remember you for ever and ever," the actor tweeted.

Nimrat Kaur said there will be no one in the industry who could do what Khan did in her lifetime.

"Saroj ji’s name introduced the word ‘choreographer’ to my life. A genius who immortalised stars and the music that defined an era with her iconic work. May her loved ones find strength and courage at this terrible hour. There’ll never be another...#RIPSarojKhan #Legend #Masterji" she said.

Genelia Deshmukh said she is grateful to have worked with the legendary artiste.

"RIP Saroji ... I thank God I got a chance to be choreographed by you...Prayers and Strength to the Family... #SarojKhan" she said.

"Woke up to the heartbreaking news of the legendary choreographer #SarojKhan’s demise. Her iconic dance moves inspired me at a very young age. Rest in peace Saroj Ji. You are truly irreplaceable," tweeted Tamannaah Bhatia.

Rakul Preet Singh mourned that her dream of working with Khan will remain unfulfilled.

"Always dreamt of doing at least one song Choreographed by her. Your grace and contribution to Indian cinema shall always be remembered. May your soul RIP. Strength to the family," she said.

Filmmaker Sanjay Gupta said he learnt a lot while working with Khan.

"The first song I conceived 'Tamma Tamma Loge' to 'Dil Dil Dil' the first song of my debut film 'Aatish' we’re choreographed by the legendary Saroj Khan. Learnt so much from her. RIP Saroj Ji and keep smiling like you always did," he wrote on the micro-blogging site.

"Saroj Khan my beloved Masterji. #RIPSarojKhan From Music Videos to films we had a long journey together. Now you’ve left me and gone. I will do and make what we spoke about one day, my promise to you," tweeted filmmaker Kunal Kohli.

Khan, a three-time National Award winner, was not keeping well for some time. She was admitted to Guru Nanak Hospital in Bandra last Saturday after she complained of breathing issues. She had tested negative for Covid-19.

The veteran choreographer is survived by son Raju Khan and daughter Sukaina Khan.

Her funeral was held on Friday morning at a cemetery in suburban Malad.

New Delhi, Feb 12: The Centre on Wednesday said the NRC data in Assam is safe even though some technical issues were visible and that will be resolved soon.

The Union Home Ministry clarification came in view of reports that data of the final list of the National Register of Citizens has been made offline from its official website.

"The NRC data is safe. Some technical issues are in visibility on cloud. These are being resolved soon," a home ministry spokesperson said.

The data was not available for a couple of days and it created panic in the public, mostly among the people excluded from the list as the rejection certificates were yet to be issued.

NRC State Coordinator Hitesh Dev Sarma accepted that the data has been made offline, but refuted the allegation of any "malafide" intent in it.

The cloud service for the huge set of data was provided by IT firm Wipro and their contract was till October 19 last year. However, this was not renewed by the previous coordinator.

So, the data got offline from December 15 after it was suspended by Wipro, Sarma said.

He said the state coordination committee had decided to do necessary formalities in its meeting on January 30 and wrote to the Wipro during the first week of February.

"Once Wipro makes the data live, it will be available for public. We hope people will be able to access it in the next 2-3 days," Sarma said.

The complete detail of exclusion and inclusion of bonafide Indian citizens in the NRC was uploaded on its official website http://www.nrcassam.nic.in after the final list was published on August 31, 2019.

The final NRC was published by excluding 19,06,657 persons. A total of 3,11,21,004 names were included out of 3,30,27,661 applicants.

After the earlier NRC State Coordinator Prateek Hajela relinquished the charge on November 11 following his transfer to home state Madhya Pradesh on a direction from the Supreme Court, Sarma was appointed in his place on November 9.

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.